Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Helson

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Cancer Clinical Trials|January 1, 1981
Flow cytometric analysis of bone marrow in a patient with resistant neuroblastomaL Helson, F Traganos, D Miller
International Journal of Radiation Oncology, Biology, Physics|April 1, 1981
Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: a pilot studyL Helson, B Jereb, R Vogel
Anti-Cancer Drugs|August 1, 1995
Camptothecin cytotoxic effects in vitro: dependency on exposure duration and doseL Helson, C Helson, S Ainsworth
Lancet (London, England)|November 6, 1976
Lack of effect of pretreatment blood-transfusions on drug-induced myelodepressionL Helson, E Polesir, M Silverman
Neurochemical Research|December 1, 1993
delta-Aminolevulinic acid effects on neuronal and glial tumor cell linesL Helson, S Braverman, J Mangiardi
Cancer Drug Delivery|January 1, 1984
Importance of clinical exposure on verapamil enhancement of adriamycin-vincristine cytotoxicity in human neuroblastomaL Helson, B Member, C Helson
Anticancer Research|September 1, 1995
Hemin toxicity in a human epithelioid sarcoma cell lineS Braverman, C Helson, L Helson
Experimental Cell Biology|January 1, 1979
Effects of murine tumor necrosis factor on heterotransplanted human tumorsL Helson, C Helson, S Green
Annals of Clinical and Laboratory Science|July 1, 1975
Diagnostic value of cytologic specimens obtained from children with cancerL Helson, P Krochmal, S I Hajdu
Biochemical Pharmacology|October 15, 1974
Papaverine-induced changes in cultured human melanoma cellsL Helson, K Lai, C W Young
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Cancer Clinical Trials|January 1, 1981
Flow cytometric analysis of bone marrow in a patient with resistant neuroblastomaL Helson, F Traganos, D Miller
International Journal of Radiation Oncology, Biology, Physics|April 1, 1981
Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: a pilot studyL Helson, B Jereb, R Vogel
Anti-Cancer Drugs|August 1, 1995
Camptothecin cytotoxic effects in vitro: dependency on exposure duration and doseL Helson, C Helson, S Ainsworth
Lancet (London, England)|November 6, 1976
Lack of effect of pretreatment blood-transfusions on drug-induced myelodepressionL Helson, E Polesir, M Silverman
Neurochemical Research|December 1, 1993
delta-Aminolevulinic acid effects on neuronal and glial tumor cell linesL Helson, S Braverman, J Mangiardi
Cancer Drug Delivery|January 1, 1984
Importance of clinical exposure on verapamil enhancement of adriamycin-vincristine cytotoxicity in human neuroblastomaL Helson, B Member, C Helson
Anticancer Research|September 1, 1995
Hemin toxicity in a human epithelioid sarcoma cell lineS Braverman, C Helson, L Helson
Experimental Cell Biology|January 1, 1979
Effects of murine tumor necrosis factor on heterotransplanted human tumorsL Helson, C Helson, S Green
Annals of Clinical and Laboratory Science|July 1, 1975
Diagnostic value of cytologic specimens obtained from children with cancerL Helson, P Krochmal, S I Hajdu
Biochemical Pharmacology|October 15, 1974
Papaverine-induced changes in cultured human melanoma cellsL Helson, K Lai, C W Young
Pageof 14